7.2 Dilation & cycloplegia (agents, contraindications)

Key Takeaways

  • Tropicamide is the short-acting workhorse mydriatic (weak cycloplegia, 4-8 h); phenylephrine gives mydriasis with NO cycloplegia.

  • Cyclopentolate and atropine are stronger, longer cycloplegics used for cycloplegic refraction; atropine lasts up to 1-2 weeks.

  • Before dilating, assess anterior chamber depth (Van Herick assessment when indicated) to avoid precipitating acute angle-closure glaucoma in an occludable angle.

  • Phenylephrine 10% is contraindicated in infants under one year and in patients with hypertension or thyrotoxicosis. Strong antimuscarinic agents may cause systemic effects.

  • Informed consent covers temporary blur, photophobia, and no driving until vision clears; warn dilated patients that severe pain, halos, or nausea signal angle closure.

Last updated: November 2026

Dilation and Cycloplegia

Pupillary dilation (mydriasis) and cycloplegia (paralysis of accommodation) are among the most common technician-administered procedures. Dilation widens the pupil so the physician can examine the crystalline lens, vitreous, retina, and optic nerve. Cycloplegia relaxes the ciliary muscle so an accurate refraction can be obtained, especially in children and hyperopes whose accommodation masks their true refractive error.

Why cycloplegic refraction matters

Children have powerful accommodation that can hide latent hyperopia and produce inconsistent manifest refractions. By temporarily paralyzing the ciliary muscle, a cycloplegic agent reveals the eye's true, relaxed refractive state and is essential when evaluating accommodative esotropia, amblyopia, and pseudomyopia. This is why the physician often orders cyclopentolate or atropine for a pediatric exam rather than the shorter-acting tropicamide used for a routine adult dilated fundus check. The technician should understand that the choice of agent reflects both the depth of cycloplegia needed and how long the patient can tolerate blurred near vision afterward.

The agents

Two receptor mechanisms produce dilation. Sympathomimetics stimulate the iris dilator muscle; anticholinergics (parasympatholytics) block the iris sphincter and, for the stronger agents, the ciliary muscle.

  • Tropicamide (0.5%, 1%) is a short-acting anticholinergic. It produces mydriasis with weak-to-moderate cycloplegia. Onset is typically 15–30 minutes and mydriasis usually reverses in 4–8 hours, making it the workhorse for routine dilated fundus exams.
  • Phenylephrine (2.5%, 10%) is a sympathomimetic that produces mydriasis with no cycloplegia. It is often combined with tropicamide for maximal dilation. The 10% label lists hypertension, thyrotoxicosis and age under one year as contraindications, and warns about serious cardiovascular reactions.
  • Cyclopentolate (0.5%, 1%, 2%) is a stronger, longer anticholinergic used for cycloplegic refraction; onset is 30-60 minutes and duration up to 24 hours. It can cause transient CNS effects in children such as drowsiness and disorientation.
  • Atropine (1%) is the strongest and longest cycloplegic, lasting one to two weeks. It is used for cycloplegic refraction in young children and to treat amblyopia and uveitis-related pain. Its long duration and systemic anticholinergic toxicity (dry mouth, flushing, tachycardia, fever) demand careful counseling.
  • Homatropine and scopolamine are intermediate-duration alternatives.

Onset and duration at a glance

AgentClassCycloplegiaOnsetDuration
TropicamideAnticholinergicWeak-moderate15-30 min4-8 h
Phenylephrine 2.5%SympathomimeticNone20-30 min3-5 h
Cyclopentolate 1%AnticholinergicStrong25–75 min to peak cycloplegiaAccommodation usually recovers in 6–24 h
HomatropineAnticholinergicModerate30-60 min1-3 days
Atropine 1%AnticholinergicStrongest30-40 min7-14 days

Contraindications and the angle-closure risk

The most important safety step before dilation is assessing the anterior chamber depth and drainage angle. Dilating a patient with a shallow anterior chamber or an occludable (narrow) angle can precipitate acute angle-closure glaucoma, an emergency in which the mid-dilated iris blocks aqueous outflow and IOP spikes. Before dilating, the technician should:

  • Estimate anterior chamber depth using the Van Herick technique at the slit lamp or a penlight oblique-illumination (eclipse) test.
  • Review history for prior angle-closure attacks, very shallow chambers, or an iris that appears bowed forward.
  • Ask about a known allergy to the agent.

Before using phenylephrine 10%, verify the order and screen for contraindications in the product label, including age under one year, hypertension and thyrotoxicosis. Cardiovascular disease requires particular caution because of possible systemic reactions. Alert the clinician to risk factors for angle closure or prior adverse reactions before administering dilation drops.

Reversal, consent, and driving precautions

There is no routine reversal agent that technicians administer; dilation is allowed to wear off. Historically dapiprazole was used to reverse mydriasis but is no longer marketed, and pilocarpine is not used casually because of its side effects.

Before instilling drops under the clinician’s order, follow the clinic’s consent process. Explain what dilation is, why it is needed, and its temporary effects: blurred near vision, difficulty reading, and light sensitivity (photophobia) lasting several hours, longer for cyclopentolate and days for atropine. Advise patients not to drive until vision returns to normal, and confirm they have sunglasses or a driver, because glare and blurred vision impair driving. Warn every patient, but especially those flagged with narrow angles, to seek immediate care if they develop severe eye pain, headache, nausea, halos around lights, or markedly blurred vision after dilation, as these are signs of angle closure. Documenting the drops given, concentrations, times, and the consent discussion completes the procedure and protects both patient and practice.

Instillation and pediatric considerations

For dilation, verify the ordered agent, strength, patient and eye. Use clinic-approved technique and punctal occlusion when directed to reduce systemic absorption. Pediatric dosing and delivery depend on the prescribed product and age. Record pre-dilation findings, time, agent, strength and laterality. Flag prior severe reactions and check with the clinician before additional doses.

Test Your Knowledge

Which dilating agent produces mydriasis WITHOUT cycloplegia?

A

Tropicamide

B

Phenylephrine

C

Cyclopentolate

D

Atropine

Test Your Knowledge

Which cycloplegic agent has the longest duration of action, lasting up to one to two weeks?

A

Tropicamide

B

Cyclopentolate

C

Homatropine

D

Atropine

Test Your Knowledge

Before dilating a patient, why should the technician assess the anterior chamber depth using the Van Herick technique?

A

To avoid precipitating acute angle-closure glaucoma in an occludable angle

B

To choose the correct drop concentration for refraction

C

To measure the patient's refractive error

D

To detect a chemical burn on the ocular surface

Sections you finish are checked off in the contents.